sickle cell disease – Faulty Drugs

Wednesday, October 16, 2024

Latest:

Faulty Drugs

Faulty Pharmaceutical Drugs Resources

Drug Recalls OXBRYTA

October 4, 2024

Pfizer withdraws all lots of OXBRYTA (voxelotor)

Pfizer has voluntarily withdrawn all lots of OXBRYTA (voxelotor), a treatment for sickle cell disease (SCD), from the market due